As the biopharmaceutical industry remains under pressure to address a high attrition rates in drug development, Cynbiose provides strategic decision-making support thanks to well-characterized and standardized physiopathological models.
We offer our services and expertise to all the actors involved in the development of new therapies: big pharmas, biotechs, start-ups and academic research teams.
We aim at providing valuable services with nonuman primates efficacy models implemented according to controlled and recognized quality standards, such as Good Laboratory Practices and AAALAC certification.
Cynbiose provides flexible and exploratory preclinical studies, with a R&D mindset.
- In-house non-clinical research capabilities :
– Exploratory pharmacokinetics and toxicity studies & derisking studies
– Translational models for efficacy studies
– Regulatory studies
- Therapeutic areas :
– Infectious diseases
– Inflammatory diseases
– CNS diseases
– Metabolic diseases
– Cardio and neurovascular diseases